Cytek Biosciences Inc. Registered Shares DL -,001
- BID
3.94
- ASK
3.96
- 15,228 Units2,525 Units
- 07/21, 21:31:38 PM
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
50.00%
Market Cap
-
P/E Ratio
0.00
Dividend Yield
0.00 %
Earnings per Share
-0.46 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 3.94 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 09:31:37 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 4.02 | 3.9 |
| PREV. DAY'S PRICE | 4.02 | (07/20) |
| CHANGE DAY BEFORE | -0.08 | -1.99 % |
| 52 WEEK HIGH / LOW | 5.5 (11/17) | 2.64 (07/22) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | -0.08 | -0.04 | -0.46 | -0.31 | -0.24 |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | - | - | - | - | - |
PRICE - BOOK RATIO | 3.03 | 2.12 | 1.90 | - | - |
PRICE - SALES RATIO | 6.39 | 4.23 | 3.20 | - | - |
PRICE - CASH FLOW RATIO | 233.63 | 33.40 | - | - | - |
Master Data
| WKN | A3CVW1 |
| ISIN | US23285D1090 |
| SYMBOL | 8EQ |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | CYTEK BIOSCIENCES DL-,001 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 1.52 % | 23.31 % | 4.69 % | -11.06 % | 50.00 % | -47.79 % | - | -5.63 % |
| HIGH | 4.16 | 4.16 | 4.20 | 4.82 | 5.50 | 8.55 | - | 5.05 |
| LOW | 3.68 | 3.28 | 2.84 | 2.84 | 2.64 | 2.14 | - | 2.84 |
Dividende
pro Aktie
CYTEK BIOSCIENCES DL-,001 does not deliver dividend information
Company profile
Cytek Biosciences, Inc. is a life sciences technology company, which engages in the provision of cell analysis tools by leveraging novel technical approaches. Its products include Cytek Aurora CS, Cytek Aurora, Cytek Northern Lights, and Cytek NL-CLC. The company was founded by Wenbin Jiang and Ming Yan in 1992 and is headquartered in Fremont, CA.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.